Tag Archives: Growth

Shares of ASML, the Dutch semiconductor equipment giant, tumbled 11% on Wednesday after the company announced it could no longer confirm that it will grow in 2026. The drop wiped out over $30 billion in market value and sent shockwaves through global tech markets, as investors digested the implications for the broader semiconductor and AI industries. The selloff followed ASML’s …

Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta TherapeuticsView Full Coverage on Google News Source link

NEW YORK (AP) — Halfway through 2025, a few music trends have become clear, according to Luminate’s 2025 Midyear Report, which was released Wednesday: — In the U.S. and globally, more music is being streamed than ever before… — But growth has slowed. — And in the U.S. specifically, there’s been a resurgence in Christian music and “recession pop.” In …

ASML Stock Falls After Growth Warning in Earnings. Tariffs Rattle Investors.  Barron’s ASML Shares Slump as Tariff Uncertainty Prompts Growth Warning  The Wall Street Journal ASML CFO Says Trade War Worries Clients More Now Than in April  Bloomberg.com ASML Hedges 2026 Growth Outlook as Trade Wars Weigh on Sales  Yahoo Finance ASML shares drop 6.5% after the chip giant says it can’t confirm that …

ASML Shares Slump as Tariff Uncertainty Prompts Growth Warning  The Wall Street Journal ASML Stock Falls on CEO’s Warning: 2026 May Be a Flat Year  Yahoo Finance ASML shares drop 6.5% after the chip giant says it can’t confirm that it will grow in 2026  CNBC ASML shares slide after warning on revenue growth  MarketWatch ASML Stock Dives After Growth Warning in Earnings. Tariffs …

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “Obesity is a significant risk factor for breast cancer, and while it is very preliminary data, our studies in …

(Bloomberg) — ASML Holding NV Chief Executive Officer Christophe Fouquet walked back the company’s sales forecast for next year, blaming trade disputes and global tensions. Most Read from Bloomberg “We continue to see increasing uncertainty driven by macro-economic and geopolitical developments,” Fouquet said in a statement on ASML’s quarterly results Wednesday. “Therefore, while we still prepare for growth in 2026, …

ASML Shares Slump as Tariff Uncertainty Prompts Growth Warning  The Wall Street Journal ASML shares drop 6.5% after the chip giant says it can’t confirm that it will grow in 2026  CNBC ASML shares slide after warning on revenue growth  MarketWatch ASML warns it may not achieve growth in 2026, shares drop  Reuters ASML Walks Back 2026 Growth Outlook as Tariffs Muddy Outlook  Yahoo Finance …

China’s economy has beaten expectations even as US President Donald Trump’s tariffs and a prolonged crisis in the property market weigh on growth. Official figures show the world’s second largest economy grew by 5.2% in the three months to the end of June, compared to the same time last year. That’s better than the 5.1% forecast by many economists but …

China’s second-quarter GDP growth tops forecast even as US tariff risks mount  Reuters China posts 5.2% GDP growth for Q2  CNN China’s Economy Grows Steadily Despite Trump’s Tariffs  The New York Times Asia-Pacific markets mostly rise after China’s second-quarter growth beats estimates  CNBC China growth slows as trade turmoil weighs on economy  BBC Source link